Lung cancer drug Erlocip would cost 9,900 rupees for 30 tablets instead of 27,000 rupees earlier, while breast cancer treatment Docetax would be priced 1,650 rupees instead of 3,300 rupees, Cipla said in a statement on Thursday.
Cipla last month won a case against Roche Holding, which accused the Indian company of infringing patent on cancer drug Tarceva, which Cipla sells under the brand name Erlocip.
Capegard, another drug to treat metastatic colorectal and colon caner, would be priced 600 rupees for 10 tablets instead of 1,200 rupees, it said.
Long live Y. K. Hamied!! Long live Cipla!!! We dont care a Sh*t about what the west says! for Indians hamied is God!!!!
these types of steps not only benefit the patients but also the companies may be benefited because as the price is reduced the drug may be in reach of more people which increase the sale of the company.... thanks cipla
Millions and millions people in this world will be thankful for this move.